Clinical Trial Update: Signaling Mechanisms and Vascular Function in Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial led by Brigham and Women's Hospital evaluating signaling mechanisms and vascular function in Type 1 Diabetes Mellitus and Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED